Evelo Biosciences, Inc. (EVLO) DCF Valuation

Evelo Biosciences, Inc. (EVLO) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Evelo Biosciences, Inc. (EVLO) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore the financial prospects of Evelo Biosciences, Inc. (EVLO) with our user-friendly DCF Calculator! Enter your assumptions for growth, margins, and expenses to determine the intrinsic value of Evelo Biosciences, Inc. (EVLO) and inform your investment decisions.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2018		 AY2
2019		 AY3
2020		 AY4
2021		 AY5
2022		 FY1
2023		 FY2
2024		 FY3
2025		 FY4
2026		 FY5
2027
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -58.1 -86.4 -91.9 -115.4 -106.3 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .0 2.0 2.2 2.1 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -58.1 -86.4 -93.9 -117.6 -108.4 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 147.9 77.8 68.9 68.4 47.9 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 1.5 .6 1.4 1.6 1.8 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -5.5 -3.0 -1.3 -1.5 -.6 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % -0.81868 -0.81868 -0.81868 -0.81868 -0.81868 -0.81868 -0.81868 -0.81868 -0.81868 -0.81868
EBITAT -55.0 -86.6 -94.3 -118.0 -109.3 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -58.9 -90.5 -92.8 -117.2 -107.7 -1.8 .0 .0 .0 .0
WACC, % 8.64 9.14 9.14 9.14 9.14 9.04 9.04 9.04 9.04 9.04
PV UFCF
SUM PV UFCF -1.6
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt 3
Equity Value -5
Diluted Shares Outstanding, MM 4
Equity Value Per Share -1.10

What You Will Get

  • Pre-Filled Financial Model: Evelo Biosciences' actual data facilitates accurate DCF valuation.
  • Full Forecast Control: Modify revenue growth, profit margins, WACC, and other essential metrics.
  • Instant Calculations: Real-time updates guarantee you see outcomes as you adjust inputs.
  • Investor-Ready Template: A polished Excel file crafted for high-quality valuation presentations.
  • Customizable and Reusable: Designed for adaptability, enabling repeated use for in-depth forecasts.

Key Features

  • Comprehensive Financial Data: Gain access to precise historical data and future forecasts tailored for Evelo Biosciences, Inc. (EVLO).
  • Adjustable Forecast Parameters: Modify highlighted fields such as WACC, growth rates, and profit margins to fit your analysis.
  • Real-Time Calculations: Enjoy automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
  • User-Friendly Dashboard: Utilize clear charts and summaries to easily interpret your valuation findings.
  • Designed for All Skill Levels: An intuitive layout suitable for investors, CFOs, and consultants alike.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based EVLO DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
  3. Instant Calculations: The model automatically recalculates Evelo's intrinsic value.
  4. Test Scenarios: Experiment with different assumptions to assess potential valuation shifts.
  5. Analyze and Decide: Leverage the results to inform your investment or financial analysis.

Why Choose This Calculator for Evelo Biosciences, Inc. (EVLO)?

  • Precision: Utilizes accurate financial data specific to Evelo Biosciences.
  • Adaptability: Allows users to easily adjust and experiment with various inputs.
  • Efficiency: Bypass the complexities of creating a DCF model from the ground up.
  • Expert-Level: Crafted with the insight and precision expected at the CFO level.
  • Intuitive: Simple interface suitable for users without extensive financial modeling skills.

Who Should Use This Product?

  • Investors: Evaluate Evelo Biosciences’ valuation prior to making investment decisions.
  • CFOs and Financial Analysts: Optimize valuation methodologies and validate financial forecasts.
  • Startup Founders: Understand the valuation strategies of biotech companies like Evelo.
  • Consultants: Provide detailed valuation analyses and reports for clients in the biotech sector.
  • Students and Educators: Utilize real-time data to learn and teach valuation practices in biotechnology.

What the Template Contains

  • Pre-Filled Data: Incorporates Evelo Biosciences' historical financials and projections.
  • Discounted Cash Flow Model: Customizable DCF valuation model with automated calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for computing WACC based on user-defined inputs.
  • Key Financial Ratios: Evaluate Evelo's profitability, efficiency, and financial leverage.
  • Customizable Inputs: Easily modify revenue growth, margins, and tax rates.
  • Clear Dashboard: Visualizations and tables summarizing essential valuation outcomes.

No products were found matching.